Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraganglioma

被引:1
作者
Pulcrano, M
Palmieri, EA
Pagano, L
Tauchmanova, L
Rossi, A
Fazio, S
Lombardi, G
Biondi, B
机构
[1] Univ Naples Federico II, Sch Med, Dept Clin & Mol Endocrinol & Oncol, I-80131 Naples, Italy
[2] Univ Naples Federico II, Sch Med, Dept Clin Med & Cardiovasc Sci, I-80131 Naples, Italy
关键词
paraganglioma; doxazosin; hypertension;
D O I
10.1007/BF03347522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herein we report on a young girl with recurrent, functioning paraganglioma of the organ of Zuckerkandl and severe and sustained arterial hypertension (systolic pressure > 200, diastolic pressure > 120 mmHg); with evidence of cardiac damage induced by chronic cathecolamine excess. She promptly and steadily improved after the institution of doxazosin (6 mg/day) plus atenolol (50 mg bid) treatment. This case demonstrates that a correct therapeutic strategy in the long-term management of patients with inoperable catecholamine-producing neuroendocrine tumors (pheochromocytomas and paragangliomas) can maintain arterial pressure in the normal range and reverse the cardiac damage induced by chronic cathecolamine excess. (C) 2004, Editrice Kurtis.
引用
收藏
页码:774 / 777
页数:4
相关论文
共 16 条
  • [1] Functioning thoracic paraganglioma: Association with von Hippel-Lindau syndrome
    Bender, BU
    Altehofer, C
    Januszewicz, A
    Gartner, R
    Schmidt, K
    Hoffmann, MM
    Heidemann, PH
    Neumann, HPH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) : 3356 - 3360
  • [2] Pheochromocytoma: State-of-the-art and future prospects
    Bravo, EL
    Tagle, R
    [J]. ENDOCRINE REVIEWS, 2003, 24 (04) : 539 - 553
  • [4] BRAVO EL, 1991, KIDNEY INT, V40, P546
  • [5] Benign paragangliomas: Clinical presentation and treatment outcomes in 236 patients
    Erickson, D
    Kudva, YC
    Ebersold, MJ
    Thompson, GB
    Grant, CS
    Van Heerden, JA
    Young, WF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5210 - 5216
  • [6] HOEFNAGEL CA, 1994, EUR J NUCL MED, V21, P561
  • [7] KWEKKEBOOM DJ, 1993, J NUCL MED, V34, P873
  • [8] DOXAZOSIN - A NEWLY DEVELOPED, SELECTIVE ALPHA-1-INHIBITOR IN THE MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA
    MIURA, Y
    YOSHINAGA, K
    [J]. AMERICAN HEART JOURNAL, 1988, 116 (06) : 1785 - 1789
  • [9] LABETALOL AND PHEOCHROMOCYTOMA
    NAVARATNARAJAH, M
    WHITE, DC
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (10) : 1179 - 1179
  • [10] Germ-line mutations in nonsyndromic pheochromocytoma.
    Neumann, HPH
    Bausch, B
    McWhinney, SR
    Bender, BU
    Gimm, O
    Franke, G
    Schipper, J
    Klisch, J
    Altehoefer, C
    Zerres, K
    Januszewicz, A
    Smith, WM
    Munk, R
    Manz, T
    Glaesker, S
    Apel, TW
    Treier, M
    Reineke, M
    Walz, MK
    Hoang-Vu, C
    Brauckhoff, M
    Klein-Franke, A
    Klose, P
    Schmidt, H
    Maier-Woelfle, M
    Peczkowska, M
    Szmigielski, C
    Eng, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (19) : 1459 - 1466